The levels of blood BNP and the N-terminal pro-B-type natriuretic peptide (NT-proBNP) are widely measured in clinical applications for the diagnosis, risk stratification, and management of patients with heart failure, as they are the closest to optimal biomarker standards for clinical implications in HF [13]. The gene discussed is NPPB; the disease is hydrops fetalis.